Praziquantel therapy in neurocysticercosis.
Neurocysticercosis is being recognised more often now, because of advances in radio-imaging. No treatment was available for this disease till about a decade back. Praziquantel has provided new hope. From India, there are very few published reports on experience with this drug. Nine cases of neurocysticercosis are being presented, where praziquantel therapy has been tried. Five patients with tumour syndrome and one patient with a meningoencephalitic syndrome have shown a favourable response. In 3 patients with epilepsy syndrome, it is difficult to assess the role of this drug in their management. The relevant data have been presented and analysed.
Srivastava
V K
VK
Department of Surgery, J. N. Medical College, A.M.U., Aligarh.
Singhal
K C
KC
Srivastava
A
A
Agrawal
A
A
D000293:Adolescent; D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging; D003551:Cysticercosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011223:Praziquantel / Q000009:adverse effects / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
D011223:Praziquantel